Illumina price target raised to $184 from $170 at Stephens

Stephens analyst Mason Carrico raised the firm’s price target on Illumina (ILMN) to $184 from $170 and keeps an Overweight rating on the shares. The company reported Q3 results that the firm views as “relatively in line with buyside expectations,” the analyst tells investors. Looking into FY25, the firm believes new and recent product introductions and the moderating headwinds associated with the 6000/X transition should help growth accelerate, the analyst added.